First patient treated in trial of Beacon Therapeutics’ XLRP treatment
The study is enrolling male participants aged between 12 and 50 years who have a confirmed XLRP diagnosis.
Immunome seeks GSI inhibitor market entry on Phase III desmoid tumour win
argenx to discontinue Phase III trials of thyroid eye disease therapy
Aviceda Therapeutics to advance eye disease drug despite Phase IIb loss
Kenai doses first patient in Phase I trial of cell therapy for Parkinson’s
Increasing trial activity in APAC region influences commercial supply chains
Analysis
View More
Themes
View MorePatient-centric approaches thrive on wearables and remote access in trials
Experts discuss the use of artificial intelligence (AI) and patient-centric strategies in oncology clinical trials.
More themes
Data Insights
View MoreLeading innovators with viral vectors for the pharmaceutical industry
The pharmaceutical industry continues to be a hotbed of innovation, with activity driven by the evolution of new treatment paradigms,...
Discover Data Insights powered by our proprietary data
Understand the themes driving your sector, keep up with key innovation areas and track the activities of leading companies
More Insights
Buyer's Guides
View More
GlobalData Reports
View more
Digital Magazine
View MorePharma Technology Focus Magazine
Pharma Technology Focus is our digital magazine, free to read online on all devices. Click the magazine cover to read the latest issue. You can subscribe for free to have each new issue delivered to your inbox.
Pharma’s AI prospects get nudged into the future with EU’s AI act
Are regulators keeping pace with AI adoption in clinical trials?
AI-automated IVF procedures represent a new era in fertility treatment
Eli Lilly and BigHat Biosciences ink AI antibody discovery deal